[A15-12] Fingolimod - Benefit assessment according to §35a Social Code Book V (dossier assessment)
Last updated 01.07.2015
Project no.:
A15-12
Commission:
Commission awarded on 25.03.2015 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Head and nerves
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
| Project no. | Title | Status |
|---|---|---|
| A18-87 | Fingolimod (multiple sclerosis) - Benefit assessment according to §35a Social Code Book V | Commission completed |
| A11-23 | Fingolimod - Benefit assessment according to § 35a Social Code Book V (dossier assessment) | Commission completed |
| A15-48 | Fingolimod (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V | Commission completed |
| A14-21 | Fingolimod (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V (dossier assessment) | Commission completed |
Federal Joint Committee (G-BA)
2015-10-01 A G-BA decision was published.